Cellink Bioprinting AB

Cellink Bioprinting AB is a company in Goteborg, Sweden that has taken part in 9 EU-funded projects since 2021, receiving €3.4M in EU funding.

EU funding received€3.4M
EU projects9
As coordinator0
Running now4
First EU project2021
Latest project2026
CountrySweden
EU registration (PIC)886365825
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Cellink Bioprinting AB's own share of each project, not the project's full budget.

  • Horizon Europe€2.8M · 7 projects
  • Horizon 2020€566k · 2 projects

Projects

9 EU-funded projects, newest first. Each links to the official record.

  • BioFACTORyPartner

    Fully automated cell and tissue-engineered bioimplant production for orocraniofacial regeneration

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €196ktheir share
  • iTRACHAssociated partner

    Development & characterisation of a pre-vascularised tubular scaffold for tracheal regeneration that supports the formation of an iPSC-derived epithelium

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

  • CellMembranePartner

    Development of delignified nanocellulose based gas transfer scaffold membrane for artificial lung applications.

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €423ktheir share
  • SILKinkPartner

    Revolutionary silk-based bioink for 3D printing of ex vivo bone marrow models to advance drug development and personalized medicine

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €898ktheir share
  • OpenMINDPartner

    Opto-Electronic Neural Connectoid Model Implemented for Neurodegenerative Disease

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €410ktheir share
  • PRISM-LTPartner

    PRInted Symbiotic Materials as a dynamic platform for Living Tissues production

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €729ktheir share
  • BioProSPartner

    Biointelligent Production Sensor to Measure Viral Activity

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €189ktheir share
  • LIFESAVERPartner

    Living Impact on Fetal Evolution: Shelter-Analyze-Validate-Empower Regulations

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €423ktheir share
  • TRiAnklePartner

    3D BIOPRINTED PERSONALISED SCAFFOLDS FOR TISSUE REGENERATION OF ANKLE JOINT

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €143ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • additive manufacturing
  • automation
  • bacteriology
  • biomaterials
  • dementia
  • embryology
  • entrepreneurship
  • fetal medicine
  • implants
  • oncology
  • physiotherapy
  • productivity
  • sensors
  • stem cells

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime